Alexion
AcquiredAlexion is a biotech company in Boston, United States, founded in 1992. It has 1 recorded funding round, most recently a Seed in June 1993.
Alexion Global Site
- Headquarters
- Boston, Massachusetts
- Employees
- 1001–5000
- Founded
- 1992
- Business Model
- B2B
- Website
- alexion.com
- Last Round
- SeedJun 1993
- Rounds
- 1
- Acquired by
- AstraZeneca PLCDec 2020 · $39.0B
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Rare disease pharmaceutical company specializing in complement biology and orphan drugs; AstraZeneca subsidiary since 2021.
Summary
It lists 1001–5000 employees. Its most recent funding was a Seed round in Jun 1993. Investors include AstraZeneca and Venrock.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Dec 2020
Sign up to see all 3 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Acquisitions
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alexion"><img src="https://indexed.vc/api/badge/company/alexion" alt="Alexion on Indexed.vc" width="260" height="76" /></a>